We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Levels of Oxytocin and Oxyntomodulin, Adiposity and Blood Indices in Pharmacotherapy Naive Diabetic and Non-Diabetic Patients with Metabolic Syndrome.
- Authors
Naserallah, Riham; Kasabri, Violet; Akour, Amal; Khawaja, Nahla; Naffa, Randa; Bustanji, Yasser
- Abstract
Aims: Oxyntomodulin (OXM) is a 37-amino acid peptide hormone released from the gut in postprandial state, while oxytocin(OXT) is a nine amino acid neuropeptide produced by the hypothalamus; both has a broad range of actions. Our study aimed to evaluate plasma peptide hormones; OXT and OXM; as well as conicity index (CI), waist circumference (WC), waist circumference to hip circumference ratio (WHR), red cell distribution width (RDW_CV%), mean platelet volume (MPV; fL) and triglyceride to high density lipoprotein-cholesterol (TG\HDL-C) ratio in metabolic syndrome (MetS) and Type-2 diabetes mellitus (T2DM) patients. Methods: In a cross-sectional design, 30 normoglycemic lean subjects (control), 30 MetS and 29 MetS-Pre/T2DM subjects were enrolled. Enzyme-Linked Immunosorbent Assay (ELISA) was used to measure plasma OXT and OXM. The correlations among these metabolic-biomarkers as well as patients' adiposity and hematological indices were examined. Results: Median circulating levels of OXT (pg/ml) were lower in MetS and MetS-Pre/T2DM compared to control group ((median IQR) (MetS 1975.4and MetS-pre/T2DM 1403 vs. control 4176.6), p=0.009 and p=0.001, respectively). Conversely, median OXM (ng/mL) concentrations lacked any inter-group substantial variations (63023.6 (124670.05- 13246.675); for the total study pool of recruits). Neither biomarker was described as substantially different in MetS vs. MetS-pre/T2DM (p>0.05). Principally, in both MetS and MetS-pre/T2DM groups; CI, TG\HDL-C ratio, WC/HC ratio and RDW-CV% were described as markedly higher (p< 0.001) vs. controls'. Median MPV in MetS-pre/T2DM (but not in the nondiabetic MetS group's) was significantly higher vs. controls' MPV. However, all above MetS-related indices were not ascribed any statistically pronounced variations in MetS vs. MetS-pre/T2DM groups. Conclusions: In both MetS and MetS-pre/T2DM patients, OXT circulating concentrations were substantially decreased compared to lean controls, while there were not any significant variations in OXM levels between three groups.
- Subjects
PEOPLE with diabetes; DRUG therapy; OXYTOCIN -- Regulation
- Publication
Jordan Journal of Pharmaceutical Sciences, 2018, Vol 11, Issue 3, p105
- ISSN
1995-7157
- Publication type
Article